Jr. Porter et al., THE EFFECT OF DISCONTINUING DEHYDROEPIANDROSTERONE SUPPLEMENTATION ONZUCKER RAT FOOD-INTAKE AND HYPOTHALAMIC NEUROTRANSMITTERS, International journal of obesity, 19(7), 1995, pp. 480-488
OBJECTIVE: Dehydroepiandrosterone (DHEA) decreases body weight and foo
d intake of the obese Zucker rat, a model of youth-onset obesity assoc
iated with hyperphagia, The effects of discontinuing DHEA treatment on
these parameters, however, has not been investigated, This question w
as studied in rats that had been maintained on DHEA-supplemented (0.0%
, 0.06%, 0.15%, 0.3% or 0.6%) diets for 7 days. METHOD: The results we
re correlated with regional levels of hypothalamic neurotransmitters i
n rats treated with 0.6% DHEA for 7 days in a separate experiment. Neu
rotransmitter changes were evaluated after Day 0 (7 days of treatment)
, and Day+1 and Day+2 post-DHEA. RESULTS: Upon removing dietary DHEA,
rats immediately (+1 day) consumed significantly more food than while
on the DHEA-supplemented diet, Indeed, they consumed even more food th
an the group that had always been on the DHEA-free diet. This intake a
bove control lasted for as long as +9 days post-DHEA treatment. After
7 days of DHEA treatment, lateral hypothalamic (LH) serotonin (5-HT) a
nd dopamine (Dpm) were elevated significantly (P < 0.05) compared to u
ntreated controls. Norepinephrine, and 5-HIAA were not significantly d
ifferent from control, These immediate changes in 5-HT and Dpm returne
d to baseline by day 2 of post-DHEA treatment, No significant changes
occurred in either the ventromedial hypothalamus (VMH) or the paravent
ricular nucleus (PVN). CONCLUSIONS: These observations suggest that th
ere is a possible relationship between increases of LH 5-HT and Dpm wi
th 0.6% DHEA treatment, Both are inhibitory to food intake and DHEA at
the 0.6% dose causes hypophagia after 7 days of treatment (i.e. 0 day
s). Subsequent decreases of these monoamines occurred during the post-
DHEA period at both +1 and +2 days, Return of these inhibitory monoami
nes to baseline could be responsible for reversal of the hypophagia, h
owever, they do not rule out the production of a separate stimulator o
f food intake.